Market News

Oppenheimer & Company Cut By $817,173 Its Bristol Myers Squibb Co (BMY) Stake; Starbucks (SBUX)’s Sentiment Is 0.97

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company has market cap of $86.96 billion. The firm operates in four divisions: Americas; China/Asia Pacific; Europe, Middle East, and Africa; and Channel Development. It has a 31.03 P/E ratio. The Company’s stores offer coffee and tea beverages, packaged roasted whole bean and ground coffees, single-serve and ready-to-drink coffee and tea products, juices, and bottled water; an assortment of fresh food and snack offerings; and various food products, such as pastries, breakfast sandwiches, and lunch items, as well as beverage-making equipment and accessories.

Oppenheimer & Company Inc decreased Bristol Myers Squibb Co (BMY) stake by 3.62% reported in 2017Q3 SEC filing. Oppenheimer & Company Inc sold 12,971 shares as Bristol Myers Squibb Co (BMY)’s stock declined 1.04%. The Oppenheimer & Company Inc holds 345,538 shares with $22.03M value, down from 358,509 last quarter. Bristol Myers Squibb Co now has $101.26 billion valuation. The stock increased 0.06% or $0.04 during the last trading session, reaching $61.87. About 1.87M shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has declined 23.19% since January 19, 2017 and is downtrending. It has underperformed by 39.89% the S&P500.

Ratings analysis reveals 60% of Starbucks’s analysts are positive. Out of 5 Wall Street analysts rating Starbucks, 3 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. The lowest target is $64.0 while the high is $65.0. The stock’s average target of $64.50 is 5.53% above today’s ($61.12) share price. SBUX was included in 5 notes of analysts from September 21, 2016. The firm has “Outperform” rating given on Wednesday, October 19 by RBC Capital Markets. The company was maintained on Wednesday, September 28 by Wedbush. Longbow initiated the shares of SBUX in report on Wednesday, September 21 with “Buy” rating. The stock of Starbucks Corporation (NASDAQ:SBUX) has “Neutral” rating given on Monday, November 21 by Buckingham Research. The firm has “Hold” rating given on Friday, February 10 by Argus Research.

The stock increased 0.05% or $0.03 during the last trading session, reaching $61.12. About 2.29 million shares traded. Starbucks Corporation (SBUX) has risen 12.48% since January 19, 2017 and is uptrending. It has underperformed by 4.22% the S&P500.

Pacifica Capital Investments Llc holds 14.6% of its portfolio in Starbucks Corporation for 521,456 shares. Marianas Fund Management Llc owns 121,700 shares or 11.25% of their US portfolio. Moreover, Bluespruce Investments Lp has 8.78% invested in the company for 867,279 shares. The New York-based Two Creeks Capital Management Lp has invested 7.54% in the stock. Consulta Ltd, a United Kingdom-based fund reported 900,000 shares.

Analysts await Starbucks Corporation (NASDAQ:SBUX) to report earnings on January, 25. They expect $0.57 earnings per share, up 9.62% or $0.05 from last year’s $0.52 per share. SBUX’s profit will be $811.00 million for 26.81 P/E if the $0.57 EPS becomes a reality. After $0.55 actual earnings per share reported by Starbucks Corporation for the previous quarter, Wall Street now forecasts 3.64% EPS growth.

Since January 1, 0001, it had 0 insider purchases, and 2 selling transactions for $4.70 million activity.

Since September 6, 2017, it had 1 insider purchase, and 2 sales for $646,385 activity. Caldarella Joseph C sold $560,400 worth of stock or 9,340 shares. 4,000 shares valued at $249,187 were bought by Samuels Theodore R. II on Friday, December 15. On Tuesday, December 12 the insider Lynch Thomas J. Jr. sold $335,172.

Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 3 Sell and 10 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 69 analyst reports since July 28, 2015 according to SRatingsIntel. The firm earned “Equal Weight” rating on Friday, April 29 by Barclays Capital. Piper Jaffray maintained Bristol-Myers Squibb Company (NYSE:BMY) on Thursday, July 27 with “Hold” rating. Jefferies maintained Bristol-Myers Squibb Company (NYSE:BMY) rating on Tuesday, June 14. Jefferies has “Hold” rating and $78 target. Barclays Capital maintained it with “Equal-Weight” rating and $65 target in Friday, September 9 report. The stock has “Hold” rating by SunTrust on Monday, October 16. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Buy” rating given on Monday, July 17 by Jefferies. The firm has “Sell” rating by BMO Capital Markets given on Sunday, July 23. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Outperform” rating given on Monday, May 9 by Credit Suisse. The company was upgraded on Friday, January 22 by Berenberg. On Monday, July 10 the stock rating was maintained by Cowen & Co with “Hold”.

Oppenheimer & Company Inc increased Micron Technology Inc (NASDAQ:MU) stake by 11,535 shares to 170,807 valued at $6.72 million in 2017Q3. It also upped Spdr Ser Tr stake by 10,743 shares and now owns 25,227 shares. Broadcom Ltd was raised too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *